SCAXF yields 153846.15% · PFE yields 6.13%● Live data
📍 SCAXF pulled ahead of the other in Year 1
Combined, SCAXF + PFE cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of SCAXF + PFE for your $10,000?
Sparta Capital Ltd. provides specialized energy capturing, converting, optimizing, and related services to the commercial sector. It offers viable options for helping manufacturers reduce waste, save resources, save money, and lower their carbon footprint; upcycles end-of-life electronic components; and sequesters C02 emissions through waste diversion and converts biomass waste into consumables. The company also distributes specialized photoluminescent exit signs and egress pathway marking to reduce the consumption of carbon based electricity; and measures and monitors energy use in commercial buildings and manufacturing facilities, as well as offers turnkey solutions and ongoing support. In addition, it delivers energy management and power quality solutions and services, including harmonic mitigation and power factor correction in industrial and commercial areas. Further, the company offers TruckSuite that provides fleet owners/operators with comprehensive maintenance, including roadside emergency assistance; emergency repair with competitive pricing, and complete warranty coverage; TripVision, an integrated vehicle health and safety management system; TreeFrog Transportation Optimization System; and Sparta Health, a streamlined process for accessing personal protective equipment. Sparta Capital Ltd. was incorporated in 1988 and is headquartered in Toronto, Canada.
Full SCAXF Calculator →Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Full PFE Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.